Since the suppression of TNF-α production and augmentation of IL-10 expression are thought to be a favorable approach for treating RA [34–36], we speculated that the administration of TJ-20 could be an ideal therapy for arthritis. This evidence concerns the gene IL10 and arthritic joint disease.